Monoallelic deletion of BCMA is a frequent feature in multiple myeloma

Blood Adv. 2023 Nov 14;7(21):6599-6603. doi: 10.1182/bloodadvances.2023010025.

Mehmet Kemal Samur^{1

2}, Anil Aktas Samur^{1

2

3}, Jill Corre⁴, Romain Lannes¹, Parth Shah^{3

5}, Kenneth Anderson³, Hervé Avet-Loiseau⁴, Nikhil Munshi^{3

6}

¹ Department of Data Science, Dana-Farber Cancer Institute, Boston, MA.
² Department of Biostatistics, Harvard T. H. Chan School of Public Health Boston, MA.
³ Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
⁴ Unit of Genomics in Myeloma, University Cancer Center of Toulouse Institut National de la Santé, Toulouse, France.
⁵ Section of Hematology, Dartmouth Cancer Center, Dartmouth Hitchcock Medical Center, Lebanon, NH.
⁶ Veterans Affairs (VA) Boston Healthcare System, Boston, MA.

No abstract available

Publication types